Glenmark Life Sciences carries factors such as strong growth in topline, healthy bottom-line expansion, robust margins, industry-leading return ratios, leadership position in APIs, and reasonable valuations.
Min Investment
₹14,400
IPO Size
₹1,514 Cr
IPO Status
Closed
Quantity in 1 Lot
20
Max Bid allowed
13
Listing Exchange
NSE
IPO Application Timeline of Glenmark Life Sciences Limited
Open Date27 Jul 2021
Close Date29 Jul 2021
Allotment Date3 Aug 2021
Key Statistics
Bid Opening Date
27 Jul 2021
Bid Closing Date
29 Jul 2021
Allotment Date
3 Aug 2021
Issue Size
₹1,514Cr
Quantity in 1 lot
20
Frequently Asked Questions of Glenmark Life Sciences Limited IPO
What is the size of the Glenmark Life Sciences Limited IPO?
The size of the Glenmark Life Sciences Limited IPO is ₹1,514Cr .
What is 'pre-apply' for Glenmark Life Sciences Limited IPO?
'Pre-apply' for Glenmark Life Sciences Limited IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.
When will my Glenmark Life Sciences Limited IPO order be placed?
Your Glenmark Life Sciences Limited IPO order will be placed on 27 Jul 2021.
What are the open and close dates of the Glenmark Life Sciences Limited IPO?
The open and close dates of the Glenmark Life Sciences Limited IPO are 27 Jul 2021 to 29 Jul 2021.
What is the lot size and minimum order quantity of the Glenmark Life Sciences Limited IPO?
The lot size and minimum order quantity of the Glenmark Life Sciences Limited IPO are 20 and 20 respectively.
What would be the listing gains on the Glenmark Life Sciences Limited IPO?
The potential listing gains on the Glenmark Life Sciences Limited IPO will depend on various market factors and cannot be predicted with certainty.